
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [APLS] Apellis Pharmaceuticals Inc
Data updated 2024-Jun-25 (Tuesday)Compare current performance/technical metrics to history for Apellis Pharmaceuticals Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2024-Jun-25 Tuesday
Day Change | +5.15% Top | Day Volatility | 6.34% Mid |
Streak | ↑ 2 days Top | % Streak | +6.12% Top |
RSI | 46 Mid | CCI | -63.9 Mid |
MACD | 0.05 Mid | ATR | 1.99 Mid |
ADX | 31.1 Mid | SSO | 18.7 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +0.17% Mid | 10.05% Mid | +2.70% Top |
10-day | -3.12% Mid | 16.91% Mid | -0.70% Mid |
20-day | -0.52% Mid | 16.91% Low | -0.62% Mid |
50-day | -21.99% Mid | 41.76% Mid | -7.13% Mid |
100-day | -36.17% Low | 92.09% Mid | -23.05% Low |
200-day | -6.02% Mid | 110.50% Mid | -23.12% Mid |
Choose Metric type
Select Performance timeframe above to analyze
On 2024-Jun-25, Apellis Pharmaceuticals Inc had:daily change of +5.15% intraday volatility of 6.3% 2 ↑(up) day streak yielding +6.12% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2024-Jun-25 value annotated for comparison
Related to Apellis Pharmaceuticals Inc
Information for Apellis Pharmaceuticals Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-22 on Google
SEC Reports : Quarterly reports around 2025-May-22 on SEC Edgar
Compare Apellis Pharmaceuticals Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Apellis Pharmaceuticals Inc
Industry : Biotechnology industry performance which includes Apellis Pharmaceuticals Inc